What is the proper protocol for prescribing short-acting insulin (SSI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescribing Short-Acting Insulin Protocol

Short-acting insulin should be administered 15 minutes before meals with dose adjustments based on pre-meal glucose levels, targeting 90-150 mg/dL before meals and <180 mg/dL post-meal. 1

Types of Short-Acting Insulin

  • Regular human insulin: Begins working in 30 minutes, peaks at 2-3 hours, and lasts 5-8 hours 1
  • Rapid-acting analogs (lispro, aspart, glulisine): Begin working within 15 minutes, peak at 30-90 minutes, and last less than 5 hours 2

Dosing Guidelines

Initial Dosing

  • For patients new to insulin therapy requiring prandial coverage:
    • Start with 4 units per meal or 10% of the basal insulin dose 1
    • If transitioning from basal-only therapy, consider reducing basal dose by 4 units or 10% when adding prandial insulin 1

Titration

  • Increase dose by 1-2 units or 10-15% twice weekly based on post-meal glucose readings 1
  • If hypoglycemia occurs, determine cause and reduce corresponding dose by 10-20% 1

Simplified Sliding Scale (for initial adjustment)

  • For pre-meal glucose >250 mg/dL: Add 2 units of short/rapid-acting insulin 1
  • For pre-meal glucose >350 mg/dL: Add 4 units of short/rapid-acting insulin 1
  • Stop sliding scale when not needed daily 1

Administration Timing

  • Regular insulin: Administer 15-30 minutes before meals 3
  • Rapid-acting analogs: Administer 0-15 minutes before meals 3
  • Do not use rapid or short-acting insulin at bedtime due to risk of nocturnal hypoglycemia 1

Mixing Guidelines

  • Visual inspection before use: rapid and short-acting insulins should appear clear 1
  • When mixing with other insulins:
    • Rapid-acting insulin can be mixed with NPH insulin 1
    • When rapid-acting insulin is mixed with intermediate/long-acting insulin, inject within 15 minutes before a meal 1
    • Insulin glargine should NOT be mixed with other insulins due to its low pH 1
    • Avoid mixing short-acting and lente insulins unless patient is already well-controlled on this mixture 1

Monitoring Protocol

  • Check blood glucose before meals and 2 hours after meals 4
  • Target ranges:
    • Fasting and pre-meal: 80-130 mg/dL 4
    • 2-hour post-meal: <180 mg/dL 4
  • For hospitalized patients, maintain blood glucose <180 mg/dL to minimize complications 5

Adjusting for Special Situations

Hospital Setting

  • In non-critical care settings, use scheduled insulin orders rather than sliding scale alone 1
  • Align insulin injections with meals for patients who are eating 1
  • For patients with poor oral intake, consider basal insulin with correction doses 1

Older Adults

  • Consider simplifying regimen for older adults with limited self-management abilities 1
  • For older adults with prandial insulin ≤10 units/dose: Consider discontinuing prandial insulin and adding non-insulin agents 1
  • For older adults with prandial insulin >10 units/dose: Decrease dose by 50% and add non-insulin agent 1

Common Pitfalls to Avoid

  • Avoid using sliding scale insulin as the sole method of treatment 1
  • Never recap, bend, or break needles to prevent needle-stick injuries 1
  • Do not store insulin in extreme temperatures (<36°F or >86°F) to maintain potency 1
  • Avoid administering short-acting insulin at bedtime to prevent nocturnal hypoglycemia 1
  • Be cautious with insulin dosing during periods of variable food intake or acute illness 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin lispro: a fast-acting insulin analog.

American family physician, 1998

Research

Type 2 Diabetes Mellitus: Outpatient Insulin Management.

American family physician, 2018

Research

Glucose control in hospitalized patients.

American family physician, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.